Barclays »

Taro Pharmaceutical Industries shares owned by Barclays

Quarter-by-quarter ownership of Taro Pharmaceutical Industries (TARO) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Taro Pharmaceutical Industries

Tip: Access up to 7 years of quarterly data

All positions including Taro Pharmaceutical Industries held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taro Pharmaceutical Industries by Barclays

Quarter filed Position value Share count Share price at filing
2013-03-31 $32k 540 59.26
2012-12-31 $12k 240 50.00
2012-09-30 $5.0k 100 50.00

More positions owned by Barclays

Invesco Qqq Tr Fund (QQQ)
Microsoft Corp Opt Put Option (MSFT)
Ishares Tr Fund (IWM)
Apple Opt Call Option (AAPL)
SPDR S&ampP 500 ETF TR Fund (SPY)
Nvidia Corporation Opt Call Option (NVDA)
Amazon (AMZN)
Alphabet Inc Class A cs (GOOGL)
Facebook Inc cl a (META)
Tesla Motors (TSLA)
Alphabet Opt Put Option (GOOG)
Visa Opt Put Option (V)
Broadcom Opt Call Option (AVGO)
Berkshire Hathaway (BRK.B)
JPMORGAN CHASE &amp Opt Put Option (JPM)

View all positions for Barclays

Top funds holding Taro Pharmaceutical Industries

Krensavage Asset Management
BlackRock
Dimensional Fund Advisors
Brandes Investment Partners
Qube Research & Technologies
Ameriprise Financial
Geode Capital Management
Millennium Management
Arrowstreet Capital, Limited Partnership
Morgan Stanley
Northern Trust
Murchinson
Vanguard Group
ARK Investment Management
Nuveen Asset Management

View all funds holding Taro Pharmaceutical Industries